Emilio Esparza-Coss

Title: Emilio Esparza-Coss: Innovator in Medical Technology

Introduction

Emilio Esparza-Coss is a notable inventor based in Louisville, CO (US). He has made significant contributions to the field of medical technology, particularly in the area of tissue ablation using laser energy. His innovative work has the potential to enhance the precision and effectiveness of tumor treatments.

Latest Patents

Emilio holds a patent for a "System and method for correlating proton resonance frequency thermometry with tissue temperatures." This invention involves devices and systems designed to ablate tumor tissue using laser energy. The system includes a laser probe and a magnetic resonance (MR) safe temperature probe, which features an optical sensor. A bone anchor fixture is utilized to separate the laser probe from the MR safe temperature probe, preventing any interference in the data collected by the MR safe temperature probe. The technology employs Proton Resonance Frequency (PRF) thermometry to model the temperature of a pixel in an MR image adjacent to the optical sensor. The modeled pixel temperature is compared with the measured temperature, and if a threshold difference is exceeded, an intervening action is triggered.

Career Highlights

Emilio is currently associated with Medtronic Navigation, Inc., where he continues to develop innovative solutions in medical technology. His work is characterized by a commitment to improving patient outcomes through advanced medical devices.

Collaborations

Emilio has collaborated with talented professionals such as Marco D Capote and Rebecca L Vincelette. These partnerships have contributed to the advancement of his projects and the overall success of the innovations developed at Medtronic Navigation, Inc.

Conclusion

Emilio Esparza-Coss is a pioneering inventor whose work in medical technology is making a significant impact on the treatment of tumors. His innovative patent demonstrates the potential for improved patient care through advanced medical devices.